Skip to main content
    S

    SINTX Technologies Inc (SINT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.34
    -0.00 (-0.37%)

    Market Cap: $10.17M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    SINTX Technologies Inc (SINT) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    SINTX Technologies (SINT) is expected to report earnings on May 10, 2027. In the quarter ended Sep 30, 2026, SINTX Technologies reported EPS of -$0.24, above the -$0.31 estimate. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    42%(16/38)
    Avg Surprise
    -41.69%
    Streak
    1 Q

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$0.35
    Range-$0.37 - -$0.34
    5 analysts
    Revenue Consensus
    $960.50K
    Range$710.50K - $1.26M
    5 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.29
    Range-$0.30 - -$0.27
    2 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.39+26.9%
    60d ago-$0.39+26.9%
    30d ago-$0.30+5.0%
    7d ago-$0.30+5.0%
    Current-$0.29
    Revenue Consensus
    $935.00K
    Range$800.00K - $1.07M
    2 analysts

    Next Report

    SINT has an expected report date of May 10, 2027.

    SINT Earnings Call

    The latest SINT earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, SINT beat 16, missed 21 and matched 3. Revenue for the quarter ended Sep 30, 2026 was $2.19M, up 952.9% from $208000 a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.24-$0.31-$0.33 - -$0.28+22.58%BeatN/A31 up, 0 downNov 5, 2026$2.19M
    Jun 30, 2026-$0.75-$0.69-$0.81 - -$0.65-8.70%MissN/A20 up, 1 downAug 11, 2026$452000
    Mar 31, 2026-$0.70-$0.66-$0.77 - -$0.55-6.06%MissN/A20 up, 1 downMay 15, 2026$380000
    Sep 30, 2025-$3.46-$0.55-$0.55 - -$0.55-529.09%MissN/A11 up, 0 downNov 12, 2025$208000
    Jun 30, 2025-$1.05-$0.79-$0.79 - -$0.79-32.91%MissN/A10 up, 1 downAug 14, 2025$151000
    Mar 31, 2025-$1.29-$0.71-$0.71 - -$0.71-81.69%MissN/A10 up, 0 downMay 15, 2025$369000
    Dec 31, 2024-$4.37-$1.82N/A-140.11%MissN/AN/A0 up, 0 downMar 19, 2025$542000
    Sep 30, 2024-$1.99-$5.29-$7.20 - -$5.29+62.38%BeatN/A20 up, 0 downNov 12, 2024$799000
    Jun 30, 2024-$3.49-$5.31-$1,987.09 - -$5.31+34.27%BeatN/A20 up, 0 downAug 13, 2024$859000
    Mar 31, 2024-$10.00-$18.00-$18.00 - -$10.00+44.44%BeatN/A21 up, 0 downMay 13, 2024$687000
    Dec 31, 2023-$0.39-$0.75-$0.75 - -$0.75+48.00%BeatN/A10 up, 0 downMar 27, 2024$902000
    Sep 30, 2023-$133.04-$152.00-$152.00 - -$152.00+12.47%BeatN/A20 up, 0 downNov 14, 2023$678000
    Jun 30, 2023-$167.90-$140.00-$178.00 - -$140.00-19.93%MissN/A20 up, 0 downAug 8, 2023$508000
    Mar 31, 2023-$309.82-$222.00-$274.00 - -$222.00-39.56%MissN/A20 up, 0 downMay 15, 2023$539000
    Dec 31, 2022-$34.69-$5.51-$6.02 - -$5.00-529.58%MissN/A20 up, 0 downMar 29, 2023$766000
    Sep 30, 2022-$2,200.00-$2,200.00-$2,400.00 - -$2,200.000.00%In lineN/A20 up, 0 downNov 14, 2022$426000
    Jun 30, 2022-$1,814.00-$2,400.00-$2,400.00 - -$2,400.00+24.42%BeatN/A20 up, 0 downAug 12, 2022$240000
    Mar 31, 2022-$2,335.60-$2,300.00-$2,400.00 - -$2,200.00-1.55%MissN/A21 up, 0 downMay 13, 2022$129000
    Dec 31, 2021-$7.00-$11.50-$14.00 - -$9.00+39.13%BeatN/A2N/AMar 25, 2022$165000
    Sep 30, 2021-$2,286.00-$2,400.00-$2,400.00 - -$1,600.00+4.75%BeatN/A2N/ANov 12, 2021$239000
    Jun 30, 2021-$1,875.40-$2,200.00N/A+14.75%BeatN/AN/AN/AAug 12, 2021$101000
    Mar 31, 2021-$12.00-$9.00-$9.00 - -$9.00-33.33%MissN/A2N/AMay 13, 2021$101000
    Dec 31, 2020-$11,600.00-$1,800.00-$1,800.00 - -$1,600.00-544.44%MissN/A2N/AMar 22, 2021$117000
    Sep 30, 2020-$1,960.00-$1,600.00-$2,200.00 - -$1,600.00-22.50%MissN/A2N/ANov 16, 2020$66000
    Jun 30, 2020-$3,476.00-$2,800.00-$3,200.00 - -$2,800.00-24.14%MissN/A2N/AAug 12, 2020$204000
    Mar 31, 2020-$5,816.40-$3,600.00-$3,600.00 - -$3,600.00-61.57%Miss-19388100.0%1N/AMay 13, 2020$207000
    Dec 31, 2019-$41.00-$57.50-$67.00 - -$48.00+28.70%BeatN/A2N/AMar 25, 2020$252000
    Sep 30, 2019-$18,200.00-$15,400.00N/A-18.18%MissN/AN/AN/ANov 18, 2019$173000
    Jun 30, 2019-$66,200.00-$312,000.31N/A+78.78%BeatN/AN/AN/AAug 15, 2019$167000
    Mar 31, 2019$0.03-$0.70N/A+104.29%BeatN/AN/AN/AMay 16, 2019$97000
    Dec 31, 2018-$18.90-$23.10N/A+18.18%BeatN/AN/AN/AMar 11, 2019$95000
    Sep 30, 2018-$0.84-$0.73N/A-15.07%MissN/AN/AN/ANov 14, 2018N/A
    Jun 30, 2018-$1.65-$0.74N/A-122.97%MissN/AN/AN/AAug 14, 2018N/A
    Mar 31, 2018-$462,060.46-$462,000.46N/A-0.01%MissN/AN/AN/AMay 15, 2018N/A
    Dec 31, 2017-$2,130.00-$1,995.00N/A-6.77%MissN/AN/AN/AMar 29, 2018N/A
    Sep 30, 2017-$432,002.16-$360,001.80N/A-20.00%MissN/AN/AN/AOct 31, 2017N/A
    Jun 30, 2017-$18.00-$28.80N/A+37.50%BeatN/AN/AN/ASep 22, 2017$3.21M
    Mar 31, 2017-$0.18-$34.20N/A+99.47%BeatN/AN/AN/AMay 18, 2017$2.63M
    Sep 30, 2016-$1,000,000.00-$1,000,000.00N/A0.00%In lineN/AN/AN/ANov 10, 2016$3.38M
    Jun 30, 2016-$1,000,000.00-$1,000,000.00N/A0.00%In lineN/AN/AN/AAug 11, 2016$4.02M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$5.80, after -$19.85 the year before. It was -$2,002,905.20 for the year ended Dec 31, 2015, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$5.80N/A
    Dec 31, 2024-$19.85N/A
    Dec 31, 2023-$611.15N/A
    Dec 31, 2022-$6,384.29N/A
    Dec 31, 2021-$4,180.40N/A
    Dec 31, 2020-$22,852.40N/A
    Dec 31, 2019-$84,440.97N/A
    Dec 31, 2018-$462,081.85N/A
    Dec 31, 2017-$3,434,150.34N/A
    Dec 31, 2015-$2,002,905.20N/A

    Earnings Calls

    The only earnings call listed below, 2026Q2 for the period ended Jun 30, 2026, runs about 2,800 words across 4 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q2Jun 30, 20262,7624

    2026Q2 Earnings Call

    Opening remarks

    Kevin Ontiveros Chief Legal Officer Thank you, operator, and good afternoon, everyone. Earlier today, SINTX Technologies issued its financial results for the quarter ended June 30, 2026, and filed its quarterly report on Form 10-Q with the Securities and Exchange Commission. The earnings release and Form 10-Q are available in the Investor Relations section of the company's website, and a replay of this call will be available following the conclusion of today's event. Before we begin, I would like to remind everyone that statements made during this call that are not statements of historical fact are forward-looking statements. These statements include, among other things, expectations regarding revenue growth, customer orders, production and shipping timing, commercialization, market adoption, strategic relationships, operating performance, cost management, liquidity, financing, future business opportunities, and revenue guidance and expectations regarding the timing and amount of revenue recognition. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Please refer to the company's most recent Form 10-K, today's Form 10-Q, and other filings with the SEC for a discussion of these risks. SINTX undertakes no obligation to update forward-looking statements except as required by law. Unless otherwise stated, the financial results discussed today are presented in accordance with U.S. generally accepted accounting principles. Joining today's call are Eric Olson, Chairman and Chief Executive Officer; and Kevin Trask, Chief Financial Officer. Eric will begin with a review of the quarter and the company's commercial priorities. Kevin will then discuss the financial results and liquidity. Eric will conclude with the priorities for the remainder of 2026. Eric, please go ahead.

    Eric Olson Chairman and Chief Executive Officer Thank you, Kevin, and thank you to everyone joining us today. The second quarter represented meaningful progress in SINTX's transition from a development company to a commercially-focused biomaterials and medical technology platform company. Our financial results show that commercial activity is beginning to become more visible. We also make clear that our work is not complete. We must convert demand into revenue, establish repeatable medical device commercialization efforts, align our cost structure with the scale of the business, and maintain adequate liquidity. So let me begin with three key takeaways from the quarter. First, commercial activity is beginning to show up in our reported results. Second quarter revenue increased 199% year-over-year to $452,000. And product revenue increased 347% to $447,000. Gross profit increased 388% to $278,000. And gross margins improved to approximately 62% compared with 38% a year ago. These percentages are calculated obviously from a small revenue base, and we do not want to overstate them.

    Frequently Asked Questions About SINT

    When is SINTX Technologies's next earnings date?

    SINTX Technologies's next earnings report is expected for May 10, 2027.

    Did SINT beat earnings estimates last quarter?

    Yes. SINTX Technologies reported EPS of -$0.24 for the quarter ended Sep 30, 2026, above the -$0.31 estimate, a 22.58% surprise.

    What EPS do analysts expect from SINT next quarter?

    The consensus EPS estimate for SINTX Technologies for the quarter ending Dec 31, 2026 is -$0.35 from 5 analysts, with estimates from -$0.37 to -$0.34.

    How often does SINT beat earnings estimates?

    SINTX Technologies beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of -89.20%.